MedNova Hopes To Bundle X.act Carotid Stent With NeuroShield
This article was originally published in The Gray Sheet
Executive Summary
MedNova will begin European clinical evaluation of the X.act carotid artery stent later this month. The device will be used in conjunction with the firm's NeuroShield distal protection device, which received CE mark approval last week, the company says.
You may also be interested in...
Abbott Entering Embolic Protection, Carotid Stent Markets Via MedNova
Abbott Labs is anticipating FDA approval of MedNova's CardioShield embolic filter device for saphenous vein graft applications in 2003, following a Feb. 2 announcement of an exclusive worldwide distribution agreement between the companies.
Abbott Entering Embolic Protection, Carotid Stent Markets Via MedNova
Abbott Labs is anticipating FDA approval of MedNova's CardioShield embolic filter device for saphenous vein graft applications in 2003, following a Feb. 2 announcement of an exclusive worldwide distribution agreement between the companies.
PercuSurge Committed To Boston Scientific Carotid Stent Trial
PercuSurge will proceed with plans to conduct U.S. trials of its GuardWire distal protection device with Boston Scientific's WallStent for carotid angioplasty, in spite of rival Medtronic's proposed purchase of the company for $225 mil., announced Oct. 19.